Paper36735616
Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs.
Takakusa H and 5 others. Nucleic Acid Ther, 2023. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs. Papers, record 36735616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36735616
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oligonucleotides, Antisense | Major topic |
| Oligonucleotides | Major topic |
| Pharmaceutical Preparations | |
| Tissue Distribution | |
| Drug Delivery Systems |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972926 | Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms. | J Inherit Metab Dis | 2026 | https://conductscience.org/library/papers/42972926 | PubMed |
| 42899094 | RNA therapeutics in rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis: a compartment-aware translational framework. | Front Immunol | 2026 | https://conductscience.org/library/papers/42899094 | PubMed |
| 42814310 | Viral RNA-Targeting Locked Nucleic Acid Gapmers: Design and In Vitro Evaluation. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42814310 | PubMed |
| 42728797 | Recent Advancements in Drug Delivery Across the Blood-Brain Barrier in Amyotrophic Lateral Sclerosis (ALS). | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42728797 | PubMed |
| 42662926 | ESCRT-I complex enhances therapeutic efficacy of ASO drugs by regulating endosomal escape and glucose homeostasis. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42662926 | PubMed |
| 42621781 | METTL3-mediated m6A modification of circMtmr7 contributes to paclitaxel-induced peripheral neuropathy in the dorsal horn. | J Physiol | 2026 | https://conductscience.org/library/papers/42621781 | PubMed |
| 42611473 | Do Chemically Modified Oligonucleotide Therapeutics Require Environmental Risk Assessment? | Environ Sci Technol | 2026 | https://conductscience.org/library/papers/42611473 | PubMed |
| 42588437 | Chemical Modification Strategies for Therapeutic Oligonucleotides: Mechanism Compatibility, Design Trade-Offs, and Translational Barriers. | Molecules | 2026 | https://conductscience.org/library/papers/42588437 | PubMed |
| 42427508 | Viral capsid delivery of cGAMP enhances STING-dependent antitumor immune response. | bioRxiv | 2026 | https://conductscience.org/library/papers/42427508 | PubMed |
| 42125269 | Aptamer-Functionalized Nanocarriers for Bone and Joint Diseases: Engineering Design Rules and Translational Roadmap. | Small Sci | 2026 | https://conductscience.org/library/papers/42125269 | PubMed |
| 42076098 | Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic Frontiers. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076098 | PubMed |
| 41800240 | Metabolic Dysfunction-Associated Steatotic Liver Disease and Emerging Oligonucleotide Therapies. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/41800240 | PubMed |
| 41713321 | Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotides. | Eur J Med Chem | 2026 | https://conductscience.org/library/papers/41713321 | PubMed |
| 41711019 | A simple and highly sensitive LC-MS/MS bioanalytical method for phosphorodiamidate morpholino oligonucleotides in plasma. | Bioanalysis | 2026 | https://conductscience.org/library/papers/41711019 | PubMed |
| 41670633 | Chemical cleavage coupled with LCMS to report on the true diastereomeric distributions of phosphorothioate linkages in gapmer ASO. | Anal Bioanal Chem | 2026 | https://conductscience.org/library/papers/41670633 | PubMed |
| 41323797 | Antisense oligonucleotide targeting the E3 ligase RFFL potentiates CFTR modulator efficacy in CF primary bronchial epithelial cells. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/41323797 | PubMed |
| 41226561 | Application of Antisense Oligonucleotides as an Alternative Approach for Gene Expression Control and Functional Studies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226561 | PubMed |
| 41206040 | Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/41206040 | PubMed |
| 41114155 | Enhanced Protein Precipitation with Ammonia Enables Rapid, Universal Extraction of Oligonucleotides for Bioanalysis. | ACS Omega | 2025 | https://conductscience.org/library/papers/41114155 | PubMed |
| 41104480 | Rbm20 antisense oligonucleotides alleviate diastolic dysfunction in a mouse model of cardiometabolic heart failure (HFpEF). | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/41104480 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36735616
GET https://conductscience.org/api/papers/v1/36735616/cited_by?page=2